glp-1 medications side effects temporary or long-term Comparative safety and of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management GLP-1 Medications for Weight Loss:

PMID: 115 SannaSVan ZuydamNRMahajanAKurilshikovAVich VilaAVsaUet al

I know they feel the same, we have conversations in between meetings, even before we prep, we do you know, kind of go over their stories, and we speak with them

Jones et al., 2010)

patients should be counseled to report symptoms such as neck mass, dysphagia, or persistent hoarseness Contraindication : Personal or family history of MTC or MEN2 Gallbladder disease : Tirzepatide may increase risk of gallstones and cholecystitis Acute kidney injury : Dehydration from gastrointestinal adverse effects may impair renal function Pancreatitis : Patients should be counseled to report severe, persistent abdominal pain Niacin-specific safety concerns: Hepatotoxicity : Baseline liver function tests and monitoring during dose titration and periodically thereafter are recommended